[PLX] YoY Annual Result on 31-Dec-2012 [#FY]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
28-Feb-2013
Financial Year
2012
Quarter
31-Dec-2012 [#FY]
Profit Trend
YoY- 68.20%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Annual Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 4,364 15,160 11,513 34,424 8,386 6,642 388 49.65%
PBT -27,282 -29,943 -27,790 -11,618 2 28,998 31,440 -
Tax -87,566 -2,944 0 0 43,306 48,792 62,880 -
NP 58,037 -29,943 -27,790 -11,618 -36,529 -28,998 -31,440 -
Tax Rate - - - - -2,165,300.00% -168.26% -200.00% -
Total Cost -53,673 45,103 39,303 46,042 44,915 35,640 31,828 -
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin 1,329.90 -197.51 -241.38 -33.75 -435.60 -436.59 -8,103.09 -
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
EPS 0.61 -0.32 -0.30 -0.13 -0.43 -0.36 -0.41 -
EPS Diluted 0.61 -0.32 -0.30 -0.13 -0.43 -0.36 -0.41 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.